Welcome to our two newest board members! Gayathri Rajan and @kellylsims have years of experience leading tech platform companies Google and Stripe, and will bring their expertise to the next phase of our business. More here: https://t.co/QhaBteA1kq
@JShendure@biorxivpreprint@_Choi_Junhong@wchenomics Super cool! Have you guys looked into recording something that could act as a logic switch once written? Would be an interesting application beyond recording.
Very excited to partner with Roche on developing RNA therapies for Alzheimer’s, Parkinson’s and a few other genetic diseases. #ShapeLife! @shapetx.com https://t.co/2I1C0HNcAw
In this thread I provide information on inflammation and therapeutic interventions for SARS-CoV2 / COVID-19. The spirit of the thread is to encourage discussion on an important topic in light of numerous clinical interventions (see Figure below). Please read on...
This was cool to write up --
As CRISPR horizons cloud, a startup focuses on the next big thing with powerhouse potential — the RNA editing platform
https://t.co/EMNPXf1fwV
We identified for the first time a selection of three cancer driver mutations (P53, KRAS and VHL) during CRISPR-Cas9 gene editing and chart a comprehensive gene-wise editing risk map in our new work out today. This series summarizes it 1/X https://t.co/ZMqbki72qR
How many proteins molecules in a cell?
42 million in a simple cell (yeast), quantified for the first time
? N in human cell
https://t.co/a2hv20ZYdq @CellSystemsCP @CellPressNews
by @UofT